Amedisys, Inc. (NASDAQ:AMED) Files An 8-K Submission of Matters to a Vote of Security Holders
Item5.07.
|
Submission of Matters to a Vote of Security Holders. |
Amedisys, Inc. (the Company) held its annual meeting of
stockholders on Thursday, June8, 2017 (the Annual Meeting). At
the Annual Meeting, the Companys stockholders voted on four
proposals. A brief description of and tabulation of votes for
each proposal are set forth below.
Proposal 1. The Companys stockholders elected
the following nine directors for a term of one year. There were
1,924,511 broker non-votes with respect to the proposal.
|
Nominee |
For | Withheld | ||||||
|
Linda J. Hall, PhD |
29,873,285 | 163,099 | ||||||
|
Julie D. Klapstein Paul B. Kusserow |
29,872,547 29,907,671 |
163,837
128,713 |
||||||
|
Richard A. Lechleiter |
29,828,584 | 207,800 | ||||||
|
Jake L. Netterville |
29,752,602 | 283,782 | ||||||
|
Bruce D. Perkins |
29,872,727 | 163,657 | ||||||
|
Jeffrey A. Rideout, MD |
29,873,267 | 163,117 | ||||||
|
Donald A. Washburn |
29,377,529 | 658,855 | ||||||
|
Nathaniel M. Zilkha |
23,661,294 | 6,375,090 |
Proposal 2. The Companys stockholders ratified
the selection of KPMG LLP as the Companys independent registered
public accountants for the fiscal year ending December31, 2017.
There were no broker non-votes with respect to the proposal.
|
For |
Against |
Abstain |
||
|
31,473,521 |
455,120 | 32,254 |
Proposal 3. The Companys stockholders approved,
on an advisory (non-binding) basis, the compensation paid to the
Companys named executive officers. There were 1,924,511 broker
non-votes with respect to the proposal.
|
For |
Against |
Abstain |
||
|
28,875,091 |
1,095,554 | 65,739 |
Proposal 4. The Companys stockholders expressed
their preference to conduct future advisory votes on executive
compensation every year. Consistent with the recommendation of
the Board of Directors of the Company as set forth in the
Companys proxy statement for the Annual Meeting and the vote of
the stockholders at the Annual Meeting, the Board of Directors
has determined to include an advisory stockholder vote on
executive compensation in the Companys proxy materials every
year. This policy will remain in effect until the next
stockholder vote on the frequency of stockholder votes on
executive compensation.
|
OneYear |
TwoYears |
ThreeYears |
Abstain |
|||
|
24,780,486 |
4,912 | 5,235,603 | 15,383 |
About Amedisys, Inc. (NASDAQ:AMED)
Amedisys, Inc. (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks. The Company’s hospice segment provides palliative care and comfort to terminally ill patients and their families. The Company’s personal care segment provides patients with assistance with the essential activities of daily living. The Company owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 30 states within the United States, the District of Columbia and Puerto Rico.
